Cui C, Cao F, Kong II, Wu Q, et al. A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor. Diabetes Obes Metab 2024;26:592-601.
PMID: 37953687